AIP
TNYA icon

Ameritas Investment Partners’s Tenaya Therapeutics TNYA Stock Holding History

Ameritas Investment Partners’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,317
Closed -$1.89K – 3343
2025
Q1 		$1.89K Hold
3,317
– – ﹤0.01% 3072
2024
Q4 		$4.74K Hold
3,317
– – ﹤0.01% 3031
2024
Q3 		$6.4K Hold
3,317
– – ﹤0.01% 3009
2024
Q2 		$10.3K Hold
3,317
– – ﹤0.01% 2917
2024
Q1 		$17.3K Hold
3,317
– – ﹤0.01% 2615
2023
Q4 		$10.7K Hold
3,317
– – ﹤0.01% 2825
2023
Q3 		$8.46K Hold
3,317
– – ﹤0.01% 2883
2023
Q2 		$19.5K Buy
3,317
+1,100
+50% +$6.39K ﹤0.01% 2579
2023
Q1 		$6.32K Hold
2,217
– – ﹤0.01% 2825
2022
Q4 		$6.27K Hold
2,217
– – ﹤0.01% 2892
2022
Q3 		$6K Hold
2,217
– – ﹤0.01% 2903
2022
Q2 		$12K Hold
2,217
– – ﹤0.01% 2790
2022
Q1 		$26K Buy
2,217
+1,149
+108% +$13.9K ﹤0.01% 2446
2021
Q4 		$20K Hold
1,068
– – ﹤0.01% 2655
2021
Q3 		$22K Buy
+1,068
New +$22.9K ﹤0.01% 2655

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Ameritas Investment Partners's TNYA Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Tenaya Therapeutics (TNYA) in Q2 2025, closing a stake of 3,317 shares — an estimated $1.89K sold.

Ameritas Investment Partners first reported a position in TNYA in Q3 2021 and held it in 15 quarters. The position peaked at $26K in Q1 2022. 89 funds tracked by Wall St. Rank hold TNYA as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Tenaya Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,317 Tenaya Therapeutics shares in Q2 2025, an estimated $1.89K.
  • Ameritas Investment Partners first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 15 quarters.
  • Ameritas Investment Partners's Tenaya Therapeutics position peaked at $26K in Q1 2022.
  • 89 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.